Co-Diagnostics, Inc. (CODX)

5.33 -0.07 (-1.30%) At close: 04:00PM EDT

Co-Diagnostics, Inc.

2401 South Foothill Drive
Suite D
Salt Lake City, UT 84109
United States
801 438 1036
https://www.codiagnostics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 101

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Dwight H. Egan	Chairman, CEO & Pres	1.02M	N/A	1953
Mr. Brian L. Brown CPA	CFO & Company Sec.	730.62k	N/A	1976
Mr. Reed L. Benson	Gen. Counsel	385.85k	N/A	1948
Dr. Brent C. Satterfield Ph.D.	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	1977
Dr. Jesse Montgomery	Chief Scientific Officer	N/A	N/A	N/A
Mr. Andrew Benson	Head of Investor Relations	N/A	N/A	N/A
Dr. Mayuranki Almaula	Sr. VP of Overseas Operations & Strategic Alliances	N/A	N/A	N/A
Mr. Cameron Gundry	Head of Commercialization LATAM/EUR	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Co-Diagnostics, Inc.’s ISS Governance QualityScore as of June 1, 2022 is 7. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.